← All companies
OKUR
OnKure Therapeutics, Inc.
$4.02
+0.02 +0.50%
Key statistics
from XBRL data in SEC filingsMarket cap
$162M
Revenue (TTM)
$0.00
Net income (TTM)
-$58.7M
EPS (TTM)
$-4.32
P/E ratio
—
Dividend yield
—
Free cash flow
-$51.9M
Cash
$192M
Total assets
$199M
Gross margin
—
52-week range
$1.91 – $5.38
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Director or officer change; Shareholder vote results
Jun 4, 2026
8-K
Results of operations (earnings release)
May 5, 2026
10-Q
Quarter ended 2026-03-31
May 5, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events
Mar 30, 2026
10-K
Fiscal year ended 2025-12-31
Mar 12, 2026
8-K
Results of operations (earnings release)
Mar 12, 2026
8-K
Entered a material agreement
Nov 6, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Results of operations (earnings release)
Aug 12, 2025
8-K
Regulation FD disclosure
Jun 26, 2025
8-K
Shareholder vote results
May 28, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
May 6, 2025
8-K
Results of operations (earnings release)
Mar 10, 2025
10-K
Fiscal year ended 2024-12-31
Mar 10, 2025
8-K
Regulation FD disclosure; Other events
Dec 10, 2024
8-K
Changed accountants; Other events
Nov 7, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06; Regulation FD disclosure
Oct 8, 2024
8-K
Shareholder vote results
Oct 2, 2024
8-K
Other events
Sep 20, 2024
8-K
Director or officer change
Sep 13, 2024
10-Q
Quarter ended 2024-06-30
Aug 13, 2024
8-K
Results of operations (earnings release)
Aug 13, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Change in control; Director or officer change; Regulation FD disclosure
May 13, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release)
May 7, 2024
10-K/A
Fiscal year ended 2023-12-31
Apr 26, 2024
10-K
Fiscal year ended 2023-12-31
Mar 28, 2024
8-K
Results of operations (earnings release)
Mar 28, 2024
8-K
Exit or disposal costs
Feb 23, 2024
8-K
Exit or disposal costs; Other events
Dec 14, 2023
10-Q
Quarter ended 2023-09-30
Nov 13, 2023
8-K
Results of operations (earnings release)
Nov 13, 2023
8-K
Other events
Oct 30, 2023
8-K
Regulation FD disclosure; Other events
Oct 10, 2023
10-Q
Quarter ended 2023-06-30
Aug 10, 2023
8-K
Results of operations (earnings release)
Aug 10, 2023